Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis
- PMID: 27427452
- PMCID: PMC5504684
- DOI: 10.1016/S0140-6736(16)30379-8
Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis
Abstract
The burden of HIV/AIDS and other transmissible diseases is higher in prison and jail settings than in the non-incarcerated communities that surround them. In this comprehensive review, we discuss available literature on the topic of clinical management of people infected with HIV, hepatitis B and C viruses, and tuberculosis in incarcerated settings in addition to co-occurrence of one or more of these infections. Methods such as screening practices and provision of treatment during detainment periods are reviewed to identify the effect of community-based treatment when returning inmates into the general population. Where data are available, we describe differences in the provision of medical care in the prison and jail settings of low-income and middle-income countries compared with high-income countries. Structural barriers impede the optimal delivery of clinical care for prisoners, and substance use, mental illness, and infectious disease further complicate the delivery of care. For prison health care to reach the standards of community-based health care, political will and financial investment are required from governmental, medical, and humanitarian organisations worldwide. In this review, we highlight challenges, gaps in knowledge, and priorities for future research to improve health-care in institutions for prisoners.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Figures

Comment in
-
Prisoners, prisons, and HIV: time for reform.Lancet. 2016 Sep 10;388(10049):1033-1035. doi: 10.1016/S0140-6736(16)30829-7. Epub 2016 Jul 14. Lancet. 2016. PMID: 27427447 No abstract available.
-
Josiah Rich: speaking up for the incarcerated.Lancet. 2016 Sep 10;388(10049):1047. doi: 10.1016/S0140-6736(16)30901-1. Epub 2016 Jul 14. Lancet. 2016. PMID: 27427450 No abstract available.
-
African Americans, HIV, and mass incarceration.Lancet. 2016 Sep 10;388(10049):e2-e3. doi: 10.1016/S0140-6736(16)30830-3. Epub 2016 Jul 14. Lancet. 2016. PMID: 27427451 No abstract available.
Similar articles
-
Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey.BMC Public Health. 2019 Dec 4;19(1):1631. doi: 10.1186/s12889-019-8011-7. BMC Public Health. 2019. PMID: 31801496 Free PMC article.
-
HIV/AIDS, hepatitis and tuberculosis-related mortality among incarcerated people: a global scoping review.Int J Prison Health. 2022 Jan 25;18(1):66-82. doi: 10.1108/IJPH-02-2021-0018. Epub 2021 Aug 13. Int J Prison Health. 2022. PMID: 35401772 Free PMC article.
-
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.Lancet. 2016 Sep 10;388(10049):1089-1102. doi: 10.1016/S0140-6736(16)30466-4. Epub 2016 Jul 14. Lancet. 2016. PMID: 27427453 Review.
-
Healthcare resources are inadequate to address the burden of illness among HIV-infected male prisoners in Malaysia.Int J Prison Health. 2016 Dec 19;12(4):253-269. doi: 10.1108/IJPH-06-2016-0017. Int J Prison Health. 2016. PMID: 27921633
-
Hepatitis B and C in the context of HIV disease: implications for incarcerated populations.AIDS Read. 1999 Oct;9(7):481-91. AIDS Read. 1999. PMID: 12737140
Cited by
-
Stakeholder-engaged research is necessary across the criminal-legal spectrum.J Clin Transl Sci. 2022 Nov 15;7(1):e5. doi: 10.1017/cts.2022.501. eCollection 2023. J Clin Transl Sci. 2022. PMID: 36755540 Free PMC article.
-
Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons.BMC Infect Dis. 2022 Apr 15;22(1):380. doi: 10.1186/s12879-022-07354-x. BMC Infect Dis. 2022. PMID: 35428213 Free PMC article.
-
Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland's largest pre-trial prison.J Glob Health. 2018 Dec;8(2):020407. doi: 10.7189/jogh.08.020407. J Glob Health. 2018. PMID: 30140433 Free PMC article.
-
Epidemiology and Treatment of Hepatitis B in Prisoners.Curr Hepatol Rep. 2017 Sep;16(3):178-183. doi: 10.1007/s11901-017-0364-8. Epub 2017 Aug 7. Curr Hepatol Rep. 2017. PMID: 29450123 Free PMC article.
-
Distribution of HCV Genotypes Among People Who Inject Drugs in Tunisia: New Evidence for Scaling Up Prevention and Treatment Toward National Elimination Goal.Front Microbiol. 2021 Jul 27;12:697859. doi: 10.3389/fmicb.2021.697859. eCollection 2021. Front Microbiol. 2021. PMID: 34385988 Free PMC article.
References
-
- Dolan K, Wirtz AL, Moazen B, et al. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees. Lancet. 2016 published online July 14. http://dx.doi.org/10.1016/S0140-6736(16)30466-4. - DOI - PubMed
-
- Fazel S, Seewald K. Severe mental illness in 33 588 prisoners worldwide: systematic review and meta-regression analysis. Br J Psychiatry. 2012;200:364–73. - PubMed
-
- Rubenstein LS, Amon JJ, McLemore M, et al. HIV, prisoners, and human rights. Lancet. 2016 published online July 14. http://dx.doi.org/10.1016/S0140-6736(16)30663-8. - DOI - PubMed
-
- WHO, UNAIDS, & UNOCD. Effectiveness of interventions to address HIV in prisons. Geneva: World Health Organization; 2007.
-
- United Nations Office On Drugs and Crime. HIV prevention, treatment and care in prisons and other closed settings: a comprehensive package of interventions. Vienna: United Nations Office of Drugs and Crime; 2013.
Publication types
MeSH terms
Substances
Grants and funding
- T32 DA013911/DA/NIDA NIH HHS/United States
- R01 DA030762/DA/NIDA NIH HHS/United States
- R01 DA029910/DA/NIDA NIH HHS/United States
- R01 DA025943/DA/NIDA NIH HHS/United States
- P30 AI094189/AI/NIAID NIH HHS/United States
- R01 AA018944/AA/NIAAA NIH HHS/United States
- K24 DA022112/DA/NIDA NIH HHS/United States
- R01 DA033679/DA/NIDA NIH HHS/United States
- R01 DA030778/DA/NIDA NIH HHS/United States
- R01 DA030768/DA/NIDA NIH HHS/United States
- R25 DA035692/DA/NIDA NIH HHS/United States
- R01 DA027211/DA/NIDA NIH HHS/United States
- K24 DA017072/DA/NIDA NIH HHS/United States
- R25 DA037190/DA/NIDA NIH HHS/United States
- P30 AI042853/AI/NIAID NIH HHS/United States
- R01 DA021525/DA/NIDA NIH HHS/United States
- DP2 DA040236/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical